Aprepitant/Fosaprepitant Dimeglumine and Incruse Ellipta
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Indacaterol
- Aprepitant/Fosaprepitant Dimeglumine-Indacaterol and Glycopyrrolate
- Aprepitant/Fosaprepitant Dimeglumine-Indacaterol and glycopyrrolate Inhalation
- Aprepitant/Fosaprepitant Dimeglumine-Indacaterol inhalation
- Aprepitant/Fosaprepitant Dimeglumine-Indacaterol Maleate
- Aprepitant/Fosaprepitant Dimeglumine-Indapamide
- Incruse Ellipta-Apresazide
- Incruse Ellipta-Apresoline
- Incruse Ellipta-Apresoline Injection
- Incruse Ellipta-Apri
- Incruse Ellipta-Apriso
- Incruse Ellipta-Aprizio Pak